SCHEMBL10270164

SCHEMBL10270164

CCNc1ccc([N+](=O)[O-])c(N)n1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PGK1 P00558 1/20 0.42
MAPT P10636 5/20 0.41
GSK3B P49841 4/20 0.41
GSK3A P49840 3/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
KCNH2 Q12809 1/20 0.40
CACNA1C Q13936 1/20 0.40
SCN5A Q14524 1/20 0.40
CDK1 P06493 2/20 0.39
CCNB2 O95067 1/20 0.39
CCNB1 P14635 1/20 0.39
CCNB3 Q8WWL7 1/20 0.39
TXNRD1 Q16881 1/20 0.39
HCAR3 P49019 1/20 0.39
LMNA P02545 2/20 0.39
ALDH1A1 P00352 2/20 0.39
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8099294 0.88 GSK3B (0.44) MAPTGSK3BGSK3AL3MBTL1CDK1
SCHEMBL4400500 0.84 GSK3B (0.39) MAPTGSK3BGSK3AL3MBTL1CDK1
SCHEMBL6069366 0.83 GSK3B (0.46) MAPTGSK3BGSK3AL3MBTL1CDK1
SCHEMBL4669978 0.83 MAPT (0.46) MAPTGSK3BGSK3ACDK1CCNB2
SCHEMBL11651996 0.82 PGK1 (0.50) PGK1MAPTL3MBTL1KCNH2CACNA1C
SCHEMBL15651049 0.82 MAPT (0.39) MAPTGSK3BGSK3AL3MBTL1CDK1
SCHEMBL7025561 0.81 GSK3B (0.38) MAPTGSK3BGSK3AL3MBTL1CDK1
SCHEMBL3603901 0.81 MAPT (0.45) MAPTGSK3BGSK3ACDK1CCNB2
SCHEMBL27611246 0.81 GSK3B (0.42) MAPTGSK3BGSK3AL3MBTL1CDK1
SCHEMBL15972357 0.81 HRH3 (0.50) GSK3BGSK3AKCNH2CDK1CCNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1957078-B1 PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING CANCER THROUGH INHIBITION OF AURORA KINASE BAYER HEALTHCARE LLC (US) 2013-08-28 EP disclosed
EP-2137188-B1 SUBSTITUTED IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES Bayer Pharma AG (DE) 2012-06-06 EP disclosed